ERBB2 and breast carcinoma: Māori women are more likely to be diagnosed with more advanced disease and are more likely to have hormone receptor negative and HER-2 positive breast cancers [10, 26], and hence longer delays in adjuvant therapy, as demonstrated in this study are likely to have a greater impact on breast cancer survival in Māori women.